Truist Financial Corp cut its holdings in BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report) by 24.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 32,146 shares of the company’s stock after selling 10,412 shares during the period. Truist Financial Corp’s holdings in BlackRock Health Sciences Term Trust were worth $471,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also modified their holdings of BMEZ. Saba Capital Management L.P. raised its holdings in BlackRock Health Sciences Term Trust by 28.0% in the 3rd quarter. Saba Capital Management L.P. now owns 8,347,664 shares of the company’s stock worth $120,290,000 after purchasing an additional 1,827,094 shares during the period. Karpus Management Inc. grew its stake in shares of BlackRock Health Sciences Term Trust by 11.8% during the 3rd quarter. Karpus Management Inc. now owns 958,125 shares of the company’s stock valued at $13,807,000 after acquiring an additional 101,328 shares during the period. Lazard Asset Management LLC increased its holdings in BlackRock Health Sciences Term Trust by 344.8% in the 3rd quarter. Lazard Asset Management LLC now owns 642,545 shares of the company’s stock worth $9,259,000 after acquiring an additional 498,079 shares in the last quarter. LPL Financial LLC raised its stake in BlackRock Health Sciences Term Trust by 0.5% during the 3rd quarter. LPL Financial LLC now owns 274,665 shares of the company’s stock worth $3,958,000 after acquiring an additional 1,231 shares during the period. Finally, Allspring Global Investments Holdings LLC raised its stake in BlackRock Health Sciences Term Trust by 3.4% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 274,585 shares of the company’s stock worth $4,023,000 after acquiring an additional 8,985 shares during the period.
Insiders Place Their Bets
In other BlackRock Health Sciences Term Trust news, major shareholder Saba Capital Management, L.P. acquired 154,932 shares of the stock in a transaction dated Thursday, February 22nd. The shares were acquired at an average cost of 16.13 per share, for a total transaction of 2,499,053.16. Following the completion of the transaction, the insider now directly owns 19,849,928 shares of the company’s stock, valued at 320,179,338.64. The purchase was disclosed in a legal filing with the SEC, which is available at this hyperlink. In the last quarter, insiders acquired 701,207 shares of company stock worth $11,338,909.
BlackRock Health Sciences Term Trust Trading Down 0.1 %
BMEZ opened at 15.10 on Friday. The company has a 50 day simple moving average of 15.46 and a two-hundred day simple moving average of 15.07. BlackRock Health Sciences Term Trust has a 1-year low of 12.93 and a 1-year high of 16.59.
BlackRock Health Sciences Term Trust Dividend Announcement
The company also recently announced a monthly dividend, which will be paid on Friday, May 31st. Investors of record on Wednesday, May 15th will be issued a $0.09 dividend. This represents a $1.08 annualized dividend and a yield of 7.15%. The ex-dividend date of this dividend is Tuesday, May 14th.
BlackRock Health Sciences Term Trust Company Profile
BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.
See Also
Want to see what other hedge funds are holding BMEZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report).
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com’s FREE daily email newsletter.
Source: defenseworld.net
